382 related articles for article (PubMed ID: 22048466)
1. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
King DP; Paciga S; Pickering E; Benowitz NL; Bierut LJ; Conti DV; Kaprio J; Lerman C; Park PW
Neuropsychopharmacology; 2012 Feb; 37(3):641-50. PubMed ID: 22048466
[TBL] [Abstract][Full Text] [Related]
2. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
4. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
5. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
6. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
7. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
8. Varenicline: a first-line treatment option for smoking cessation.
Garrison GD; Dugan SE
Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
Tonstad S
J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
[TBL] [Abstract][Full Text] [Related]
11. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
12. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC
Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
Rose JE; Behm FM
Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
[TBL] [Abstract][Full Text] [Related]
14. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
15. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
16. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
[TBL] [Abstract][Full Text] [Related]
17. Varenicline: for smoking cessation.
Rao J; Shankar PK
Kathmandu Univ Med J (KUMJ); 2009; 7(26):162-4. PubMed ID: 20071853
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
[TBL] [Abstract][Full Text] [Related]
19. A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
Xenakis JG; Kinter ET; Ishak KJ; Ward AJ; Marton JP; Willke RJ; Davies S; Caro JJ
Pharmacoeconomics; 2011 Jun; 29(6):497-510. PubMed ID: 21452908
[TBL] [Abstract][Full Text] [Related]
20. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA
Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]